Sildenafil improves immediate posttransplant parameters in warm-ischemic kidney transplants: experimental study

Area of Science:

• Nephrology
• Transplantation
• Pharmacology

Background:

• Kidney transplantation is a vital treatment for end-stage renal disease.
• Ischemia-reperfusion injury remains a significant challenge in kidney allograft survival.
• Phosphodiesterase type 5 (PDE5) inhibitors are being investigated for their potential therapeutic effects in transplantation.

Purpose of the Study:

• To investigate the impact of the PDE5 inhibitor sildenafil on kidney grafts subjected to warm ischemia and hypothermic perfusion.
• To assess the effects of sildenafil on renal function and hemodynamics in an autotransplantation model.

Main Methods:

• A porcine model (n=9) was used, with kidneys subjected to 45 minutes of warm ischemia and 60 minutes of hypothermic pump perfusion.
• Group A (n=4) received oral sildenafil 1 hour pre-surgery; Group B (n=5) served as the control.
• Renal blood flow, vascular resistance, arterial pressure, and nitric oxide levels were measured post-autotransplantation. Histological analysis was also performed.

Main Results:

• Sildenafil administration led to significantly higher renal vascular flow and lower renal vascular resistance compared to controls.
• Nitric oxide levels were significantly elevated in the sildenafil group throughout the observation period.
• No significant differences in systemic arterial pressure or histological findings were observed between the groups.

Conclusions:

• Sildenafil demonstrates a beneficial effect on the immediate post-transplant outcomes of kidneys affected by warm ischemia.
• The observed benefits occurred without significant systemic side effects, suggesting a localized protective effect.
• These findings support further investigation into PDE5 inhibitors for improving kidney transplant success rates.